Skip to main content

Table 9 Comparison between both groups according to ICU stay and 28-day mortality

From: Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial

  Group A: control (n = 30) Group B: esmolol (n = 30) t test/χ2 P value
ICU stay (days) 16.2 ± 3.2 13.2 ± 3.31 − 3.569 < 0.001
28-day mortality (no) 21/30 14/30 − 4.282 0.0385
  1. Data presented as mean ± SD
  2. P value > 0.05 NS; *P value < 0.05 S; **P value < 0.001 HS
  3. There was a significant reduction in ICU stay and 28-day mortality of group B compared to group A (P value 0.001 and 0.0385, respectively) as shown in Table 9, Figs. 7 and 8
\